IRIS - Res&Arch Institutional Research Information System - Research & Archive

FANELLI, Carmine Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.082
EU - Europa 4.395
AS - Asia 4.083
SA - Sud America 694
Continente sconosciuto - Info sul continente non disponibili 333
AF - Africa 103
OC - Oceania 25
Totale 16.715
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.817
SG - Singapore 2.015
IT - Italia 658
IE - Irlanda 598
UA - Ucraina 590
CN - Cina 585
RU - Federazione Russa 579
BR - Brasile 537
SE - Svezia 529
HK - Hong Kong 417
DE - Germania 361
FR - Francia 336
VN - Vietnam 329
FI - Finlandia 224
GB - Regno Unito 166
BD - Bangladesh 164
CA - Canada 112
KR - Corea 96
IN - India 94
ES - Italia 87
TR - Turchia 73
AT - Austria 53
PL - Polonia 53
MX - Messico 52
AR - Argentina 50
JP - Giappone 45
ZA - Sudafrica 41
IQ - Iraq 40
NL - Olanda 38
CO - Colombia 32
UZ - Uzbekistan 32
ID - Indonesia 26
PK - Pakistan 26
SA - Arabia Saudita 22
AU - Australia 21
CH - Svizzera 21
CR - Costa Rica 21
VE - Venezuela 19
PH - Filippine 18
CZ - Repubblica Ceca 17
EC - Ecuador 17
BE - Belgio 15
MA - Marocco 15
TT - Trinidad e Tobago 15
GR - Grecia 13
GT - Guatemala 13
JO - Giordania 12
MY - Malesia 12
HN - Honduras 11
PE - Perù 11
KE - Kenya 10
NP - Nepal 10
CL - Cile 9
JM - Giamaica 9
LB - Libano 9
AZ - Azerbaigian 8
KZ - Kazakistan 8
LT - Lituania 8
RO - Romania 8
CW - ???statistics.table.value.countryCode.CW??? 7
PY - Paraguay 7
SV - El Salvador 7
TN - Tunisia 7
BO - Bolivia 6
AE - Emirati Arabi Uniti 5
BB - Barbados 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
EG - Egitto 5
IL - Israele 5
OM - Oman 5
AL - Albania 4
DZ - Algeria 4
EE - Estonia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
RS - Serbia 4
TH - Thailandia 4
UY - Uruguay 4
BH - Bahrain 3
CI - Costa d'Avorio 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
HR - Croazia 3
NG - Nigeria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
TG - Togo 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
BY - Bielorussia 2
GH - Ghana 2
HU - Ungheria 2
IM - Isola di Man 2
KG - Kirghizistan 2
KH - Cambogia 2
PA - Panama 2
Totale 16.362
Salva come PNG Salva come JPEG
Città #
Singapore 1.414
San Jose 738
Chandler 684
Dublin 599
Ashburn 561
Hong Kong 410
San Mateo 346
Boardman 279
Jacksonville 272
Santa Clara 268
Council Bluffs 219
Altamura 192
Princeton 174
Medford 172
Moscow 164
Lauterbourg 155
Beijing 152
Wilmington 144
Lawrence 129
New York 126
Perugia 121
Los Angeles 120
Munich 117
Seoul 93
Des Moines 89
Ann Arbor 88
Dong Ket 85
Andover 78
Helsinki 76
Ho Chi Minh City 70
Saint Petersburg 53
São Paulo 53
Rome 52
The Dalles 52
Frankfurt am Main 51
Valencia 50
Hanoi 46
Dallas 43
Piscataway 41
Brooklyn 40
Chicago 38
Tokyo 38
Falls Church 35
North Bergen 33
Orem 32
Warsaw 31
Montreal 30
Izmir 28
Woodbridge 27
Stockholm 26
Toronto 26
Milan 25
Norwalk 25
Nuremberg 25
Phoenix 24
San Francisco 24
Tashkent 23
Vienna 23
Atlanta 22
Denver 21
Amsterdam 20
Buffalo 20
Turku 20
London 18
Fremont 17
Rio de Janeiro 17
Baghdad 16
Istanbul 16
Shanghai 16
Amelia 15
Ankara 15
Da Nang 15
Mexico City 15
San José 15
San Paolo di Civitate 15
Charlotte 14
Falkenstein 14
Houston 14
Redmond 14
Brussels 13
Johannesburg 13
Amman 12
Haiphong 12
Boston 11
Brasília 11
Brno 11
Philadelphia 11
Auburn Hills 10
Belo Horizonte 10
Chennai 10
Poplar 10
Porto Alegre 10
Roubaix 10
Buenos Aires 9
Campinas 9
Columbus 9
Curitiba 9
Foligno 9
Goiânia 9
Guatemala City 9
Totale 9.695
Salva come PNG Salva come JPEG
Nome #
Adrenaline vs glucagon in the primacy of glucose counterregulation 181
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. 172
Different brain responses to hypoglycemia induced by equipotent doses of long-acting insulin analog detemir and human regular insulin in humans 172
Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes 168
Hypoglycemia 158
Physical activity habits and well-being among 6-year-old children: The “improving umbrian kids’ healthy lifestyle”, an uncontrolled pilot study project 155
Administration of neutral protamine Hagerdon insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial. 152
An intensive lifestyle intervention in children with attention-deficit/hyperactivity disorder 151
Physical activity level and mediterranean diet adherence evaluation in older people - observational, uncontrolled, pilot study 146
Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes 145
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia. 144
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. 141
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 141
18. Insulin required for prandial ghrelin suppression in humans 139
Diurnal Cycling of Insulin Sensitivity in Type 2 Diabetes: Evidence for Deviation From Physiology at an Early Stage 132
Comparison of pharmacokinetics and-dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes mellitus: a double-blind, randomized, cross-over study. 132
A novel surrogate index for hepatic insulin resistance. 131
Intensive lifestyle intervention is particularly advantageous in poorly controlled type 2 diabetes 130
Administration of Neutral Protamine Hagedorn insulin at bedtime versus dinner in Type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control: a randomized, controlled trial. 130
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 129
Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans 129
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes mellitus. 128
Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia 127
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. 127
Effects of an Intensive Lifestyle Intervention to Treat Overweight/Obese Children and Adolescents 125
Cognitive function in hypoglycaemia 124
Ipoglicemia: implicazioni cliniche e impatto sulla salute 122
Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs 121
Adrenergic mechanisms do not contribute to glucose counterregulation during acute insulin-induced hypoglycaemia in normal man. 120
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. 118
Insulin is required for prandial ghrelin suppression in humans 118
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. 117
Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity: A cross-sectional analysis of the RISC Study 117
Nutritional Management of Athletes with Type 1 Diabetes: A Narrative Review 116
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study. 116
Nocturnal blood glucose control in type I diabetes mellitus. 116
IMPACT OF NOCTURNAL HYPOGLYCEMIA ON HYPOGLYCEMIC COGNITIVE DYSFUNCTION IN TYPE 1 DIABETES 115
Evaluation of maximum oxygen consumption in obese adolescents before and after a multidisciplinary lifestyle intervention 115
Uso dell’analogo ad azione rapida lispro con l’analogo ad azione ritardo glargine nel trattamento intensivo del T1DM 114
Are three months multidisciplinary lifestyle intervention enough to get benefits on blood pressure in overweight/obese adults ? 114
Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. 113
Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study. 112
Counterregulatory hormone and symptom responses to insulin-induced hypoglycaemia in the postprandial state in humans 110
Effects of a supervised nordic walking program on obese adults with and without type 2 diabetes: The C.U.R.I.A.Mo. Centre experience 110
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro 109
Equipotency of insulin glargine 300 and 100 U/mL with intravenous dosing but differential bioavailability with subcutaneous dosing in dogs 109
Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. 107
The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity 107
Pivotal role of timely basal insulin replacement after metformin failure in sustaining long-term blood glucose control at a target in Type 2 diabetes. 107
Effect of Short Term Intensive Lifestyle Intervention on Hepatic Steatosis Indexes in Adults with Obesity and/or Type 2 Diabetes 107
Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting analogue at mealtime. A three month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. 106
Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans. 106
Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. 106
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules 105
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. 105
Early improvement of glucose tolerance after ileal transposition in a nonobese Type 2 diabetes rat model. 104
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 104
Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis. 103
Hyperglycemia, Both Chronic and in Short-Term Peaks, Results in Rapid Increase of Expression of Monocyte Inducible Cyclooxygenase (COX-2) in Subjects with T2DM 103
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes. 102
Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin 102
Body composition and common carotid artery remodeling in a healthy population 101
Ricoveri per ipoglicemia grave in soggetti con diabete mellito di tipo 2: impatto clinico e costi sanitari 101
Impact of BMI, Physical Activity, and Sitting Time Levels on Health-Related Outcomes in a Group of Overweight and Obese Adults with and without Type 2 Diabetes 101
Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes 99
PHARMACOKINETIC AND PHARMACODYNAMIC HEAD-TO-HEAD COMPARISON OF CLINICAL, EQUIVALENT DOSES OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC 100 U/ML IN TYPE 1 DIABETES 99
Glucagon: the effects of its excess and deficiency on insulin action 98
Intensive replacement of basal insulin in patients with Type 1 diabetes mellitus given rapid-acting insulin analogue at meal-time: a three-month comparison between administration of NPH four times daily and glargine insulin at dinner or bedtime. 96
Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia 95
Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people. 95
The impact of ideglira in treatment simplification in older adults with type 2 diabetes mellitus already on insulin therapy: The stop study 94
Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study. 94
Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: The Importance of appropriate resuspension before subcutaneous injection 94
One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort 94
Premeal Insulin Treatment During Basal-Bolus Regimen in Young Children With Type 1 Diabetes 94
Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes. 93
Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes. 92
Circulatin ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement 92
Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. 92
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. 91
Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans. 90
Ipoglicemia: cause e prevenzione 89
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study 89
Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement 89
Female Sex and Angiotensin-Converting Enzyme (ACE) Insertion/Deletion Polymorphism Amplify the Effects of Adiposity on Blood Pressure 89
"Strength gains in different age groups of overweight/obese adults: A pilot uncontrolled study" 88
Counterregulatory responses in CSII 88
Impact of recent antecedent hypoglycemia on hypoglycemic cognitive dysfunction in nondiabetic humans. 88
Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus. 87
Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus 87
A multistep approach for the stratification of the risk of severe hypoglycemia in patients with type 2 diabetes 87
L’ipoglicemia silente nella pratica clinica quotidiana: come diagnosticarla, gestirla e prevenirla 87
Obesity and carotid artery remodeling 87
Is physical activity a necessary element during Italian coronavirus disease emergency? Yes or no debate 85
Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus 84
Reversibility of unawareness of hypoglycemia in patients with insulinomas. 83
Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. 81
Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement. 81
Low levels of unmodified insulin glargine in plasma of people with type 2 diabetes requiring high doses of basal insulin 81
Late post-prandial hypoglycaemia as the sole presenting feature of secreting pancreatic beta-cell adenoma in a subtotally gastrectomized patient. 80
Totale 11.120
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.981
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022990 0 0 0 83 34 20 20 407 16 32 137 241
2022/20232.310 184 465 31 191 170 287 5 95 788 3 67 24
2023/2024982 54 105 43 33 8 8 195 14 77 39 185 221
2024/20252.340 36 230 81 126 366 65 59 182 513 167 304 211
2025/20265.525 360 325 266 603 779 408 1.004 280 738 414 179 169
2026/20271.835 193 175 346 1.121 0 0 0 0 0 0 0 0
Totale 16.715